Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 2521 AL 2535

Mitochondrial mechanisms of neuroglobin's neuroprotection

Yu Z, Poppe JL, Wang X.

Oxid Med Cell Longev. 2013;2013:756989. doi: 10.1155/2013/756989. Epub 2013 Mar 24.

Potential and problems in ultrasound-responsive drug delivery systems

Zhao YZ, Du LN, Lu CT, Jin YG, Ge SP.

Int J Nanomedicine. 2013;8:1621-33. doi: 10.2147/IJN.S43589. Epub 2013 Apr 22.

Differences between Parkinson's and Huntington's diseases and their role for prioritization of stem cell-based treatments

Hug K, Hermerén G.

Curr Mol Med. 2013 Jun;13(5):777-91. doi: 10.2174/1566524011313050009.

Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration?

Kaul B, Goyal V, Shukla G, Srivastava A, Garg A, Bader B, Danek A, Hayflick S, Behari M.

Neurol India. 2013 Mar-Apr;61(2):169-70. doi: 10.4103/0028-3886.111129.

Role of BDNF in central motor structures and motor diseases

He YY, Zhang XY, Yung WH, Zhu JN, Wang JJ.

Mol Neurobiol. 2013 Dec;48(3):783-93. doi: 10.1007/s12035-013-8466-y. Epub 2013 May 7.

Intrabodies as neuroprotective therapeutics

Messer A, Joshi SN.

Neurotherapeutics. 2013 Jul;10(3):447-58. doi: 10.1007/s13311-013-0193-6.

Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease

Edlinger M, Seppi K, Fleischhacker W, Hofer A.

Int Clin Psychopharmacol. 2013 Jul;28(4):214-6. doi: 10.1097/YIC.0b013e328361e145.

[Chorea due to TITF1/NKX2-1 mutation: phenotypical description and therapeutic response in a family]

Salvado M, Boronat-Guerrero S, Hernández-Vara J, Álvarez-Sabin J.

Rev Neurol. 2013 May 16;56(10):515-20.

Structural aspects of amyloid formation

Salvatella X.

Prog Mol Biol Transl Sci. 2013;117:73-101. doi: 10.1016/B978-0-12-386931-9.00004-0.

Scientific and ethical issues related to stem cell research and interventions in neurodegenerative disorders of the brain

Barker RA, de Beaufort I.

Prog Neurobiol. 2013 Nov;110:63-73. doi: 10.1016/j.pneurobio.2013.04.003. Epub 2013 May 7.

It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)

Aso E, Ferrer I.

Expert Opin Biol Ther. 2013 Sep;13(9):1215-9. doi: 10.1517/14712598.2013.799129. Epub 2013 May 14.

Tardive dyskinesia caused by tetrabenazine

LeWitt PA.

Clin Neuropharmacol. 2013 May-Jun;36(3):92-3. doi: 10.1097/WNF.0b013e318290cd41.

Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline

Reilmann R.

Mov Disord. 2013 Jul;28(8):1030-3. doi: 10.1002/mds.25500. Epub 2013 May 14.

Delayed onset of progressive chorea after acute basal ganglia injury

Virmani T, Greene PE, Pearson TS.

Mov Disord. 2013 May;28(5):585-7. doi: 10.1002/mds.25436.

Measuring activity in the ubiquitin-proteasome system: from large scale discoveries to single cells analysis

Melvin AT, Woss GS, Park JH, Waters ML, Allbritton NL.

Cell Biochem Biophys. 2013 Sep;67(1):75-89. doi: 10.1007/s12013-013-9621-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias